Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00005779
Status:
COMPLETED
Last Update Posted:
2021-11-01
First Post:
2000-06-03
Brief Title:
Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 IL-12 in HIV-Infected Patients Receiving Effective Anti-HIV Drug Therapy
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID